DekaBank Deutsche Girozentrale Grows Holdings in Revvity Inc. $RVTY

DekaBank Deutsche Girozentrale boosted its holdings in Revvity Inc. (NYSE:RVTY) by 0.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 84,585 shares of the company’s stock after purchasing an additional 202 shares during the quarter. DekaBank Deutsche Girozentrale’s holdings in Revvity were worth $8,255,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of RVTY. GAMMA Investing LLC raised its position in Revvity by 42.9% in the 1st quarter. GAMMA Investing LLC now owns 2,713 shares of the company’s stock valued at $287,000 after purchasing an additional 815 shares during the last quarter. Wealth Enhancement Advisory Services LLC raised its position in Revvity by 3.8% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 5,139 shares of the company’s stock valued at $544,000 after purchasing an additional 187 shares during the last quarter. Janney Montgomery Scott LLC raised its position in Revvity by 39.4% in the 1st quarter. Janney Montgomery Scott LLC now owns 10,998 shares of the company’s stock valued at $1,164,000 after purchasing an additional 3,107 shares during the last quarter. Asset Management One Co. Ltd. raised its position in Revvity by 4.4% in the 1st quarter. Asset Management One Co. Ltd. now owns 50,725 shares of the company’s stock valued at $5,367,000 after purchasing an additional 2,130 shares during the last quarter. Finally, Sequoia Financial Advisors LLC raised its position in Revvity by 7.7% during the 1st quarter. Sequoia Financial Advisors LLC now owns 27,921 shares of the company’s stock worth $2,954,000 after buying an additional 1,992 shares during the last quarter. Hedge funds and other institutional investors own 86.65% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on RVTY shares. Guggenheim started coverage on shares of Revvity in a research report on Wednesday, October 15th. They set a “neutral” rating for the company. Evercore ISI cut their price objective on shares of Revvity from $108.00 to $106.00 and set an “outperform” rating for the company in a research report on Tuesday, October 7th. Stifel Nicolaus cut their price objective on shares of Revvity from $120.00 to $110.00 and set a “hold” rating for the company in a research report on Tuesday, July 29th. Raymond James Financial restated an “outperform” rating and set a $115.00 price objective (down previously from $120.00) on shares of Revvity in a research report on Tuesday, July 29th. Finally, Barclays cut their price objective on shares of Revvity from $110.00 to $100.00 and set an “overweight” rating for the company in a research report on Thursday, October 2nd. Nine research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $116.38.

Revvity Stock Performance

NYSE:RVTY opened at $98.91 on Friday. The stock has a market cap of $11.48 billion, a PE ratio of 41.91, a price-to-earnings-growth ratio of 3.25 and a beta of 0.98. Revvity Inc. has a fifty-two week low of $81.36 and a fifty-two week high of $129.50. The firm’s fifty day simple moving average is $89.38 and its 200-day simple moving average is $92.42. The company has a quick ratio of 2.75, a current ratio of 3.33 and a debt-to-equity ratio of 0.43.

Revvity (NYSE:RVTY) last issued its quarterly earnings data on Monday, July 28th. The company reported $1.18 EPS for the quarter, beating analysts’ consensus estimates of $1.14 by $0.04. The firm had revenue of $720.28 million for the quarter, compared to analysts’ expectations of $711.26 million. Revvity had a net margin of 10.19% and a return on equity of 7.66%. The firm’s revenue was up 4.1% on a year-over-year basis. During the same period in the prior year, the company earned $1.22 EPS. Revvity has set its FY 2025 guidance at 4.850-4.950 EPS. Analysts expect that Revvity Inc. will post 4.94 earnings per share for the current fiscal year.

Revvity Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 6th. Investors of record on Friday, January 16th will be paid a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date of this dividend is Friday, January 16th. Revvity’s dividend payout ratio is presently 11.86%.

Revvity Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.